Jianguo Cheng, MD, PhD

• President of the American Academy of Pain Medicine (2018~-2019)
• Member, US Department of Health and Human Services (HHS) Pain Management Best Practices Inter-agency Task Force (PMTF Feb 21, 2018-2019)
• Member of National Academy of Medicine Action Collaborative on Countering the US Opioid Epidemic, 2018-2022.
• Member of the Centers for Medicare & Medicaid Services (CMS) Expert Work Group (EWG) on the development of the measure evaluating potential opioid overuse. 2016-2021.
• Chairman, USA Section of World Institute of Pain (2013-2015).
• Board of Directors, American Academy of Pain Medicine (AAPM) (2014-2020)
• Board of Directors, American Academy of Regenerative Medicine (AARM) (2016~)
• Academy of Medicine of Cleveland & Northern Ohio (AMCNO), 2019-2021.
• Senior Editor/Section Editor, Pain Medicine (Official Journal of American Academy of Pain Medicine), 2015-present)
• Associate Editor, Pain Practice (Official Journal of World Institute of Pain) (2011-2017)
• Scientific Advisory Board, the Association of University Anesthesiologists (AUA) (2015-2018).
• Board of Directors, American Academy of Pain Medicine (AAPM) (2013-present).
• Chairman, AAPM Scientific Review/Clinical Guideline Committee (2011-present).
• Member of National Institutes of Health Study sections/Grant review committee (National Institutes of Health Special Emphasis Panel/Scientific Review Group.
• Expert Reviewer of grant applications to the US Army Medical Research and Material Command, the Scientific Peer Advisory and Review Services division of the American Institute of Biological Sciences (AIBS).
• Published more than 260 research papers, reviews, book chapters, and abstracts.
• Received research grants of more than $4 million from the National Institutes of Health, the Department of Defense, the Lisa Dean Moseley Foundation, and other funding agencies.
• Executive Board Member, Association of Pain Program Directors (2013-2016).
• Committee Member, American Society of Anesthesiologists (ASA) Committee on Pain Medicine (2013-2017) 
• Committee Member, ASA Educational Track Subcommittee on Pain Medicine (2014~).
• Pain Medicine Examination Committee, American Board of Anesthesiology (ABA), the American Board of Physical Medicine and Rehabilitation (ABPMR), and the American Board of Psychiatry and Neurology (ABPN), (2013-2018) 
• Examiner, World Institute of Pain, Fellow of Interventional Pain Physicians Board of Examination.
• Previously worked or studied in Harvard University, University of Louisville, University of Alberta, University of Manitoba, University of Guelph, and Qingdao University.
• Trained more than 180 postdoctoral fellows, clinical fellows, and clinical research fellows.
• Received more than 60 honors and awards from institutions, societies, and government agencies.

• Leading in Healthcare Leadership Class, Cleveland Clinic Academy and Board of Governors, Cleveland, Ohio, 08/2009-05/2010.  A 10-month course focusing on leadership in healthcare, human resource management, emotional intelligence, finances, marketing, organizational culture and team building.
• Program Director Certification Program, Cleveland Clinic Education Institute, Department of Faculty Development, 09/2011-05/2012. Certification of Distinguished Development Award,  September of 2013.
• PhD, biophysics, Interdepartmental Group of Biophysics and Department of Human Biology, University of Guelph, Ontario, Canada, 1991-1995
• Postdoctoral Fellow, electrophysiology of neurons: cell membrane and receptors, Department of Physiology/Spinal Cord Research Centre, University of Manitoba Faculty of Medicine, Winnipeg, Manitoba, Canada, 1995-1996
• Postdoctoral Fellow, neural control of locomotion: neural networks and therapeutic strategies, Division of Neuroscience/Department of Physiology, University of Alberta Faculty of Medicine, Edmonton, Alberta, Canada, 1996-1998

See publications for this provider. (Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists collaborate with industry to advance medical breakthroughs. These partnerships help commercialize discoveries for public benefit while maintaining scientific integrity. To ensure transparency and minimize potential bias, Cleveland Clinic reviews these relationships and publicly discloses when physicians/scientists receive significant compensation for consulting, serve in fiduciary roles, receive royalties, or hold equity interests related to their work. We manage potential conflicts through approval processes, annual reporting, and targeted management plans.

As of 2025-07-11, Dr. Cheng has reported the financial relationships with the companies listed below.

Royalty Payments. Dr. Cheng receives or has the right to receive royalty payments for inventions or discoveries commercialized through the companies shown below:

• Springer Nature
• Boston Scientific Corporation

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.